Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Prodrugs01:30

Prodrugs

4.0K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
4.0K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

232
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
232
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.2K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Serotonergic Regulation of Nicotine Addiction: Receptor-specific Mechanisms and Therapeutic Strategies.

Current neurovascular research·2026
Same author

Development and Validation of the Healthcare Expenditure and Location Dynamics in Acute Febrile Illness (HEAL-AFI) Tool: A Community-Based Cohort Study With a Special Focus on Dengue and Chikungunya in the Urban Slum of Delhi, India.

Cureus·2026
Same author

Smart Lipid-Based Nanocarrier System for the Topical Delivery of Ocular Therapeutics Bio-Interfacing, Physicochemical Diversity, and Routing Barriers.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same author

Strategic Integration of Artificial Intelligence in Public Health System: Direction Toward a Paradigm Shift.

Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine·2026
Same author

Folic Acid-Conjugated Nanocarriers for Targeted Cancer Therapy: Recent Patents and Future Prospects.

Current gene therapy·2026
Same author

Reappraising TB preventive treatment in India: programmatic and ethical implications of subclinical tuberculosis in household contacts.

The Lancet regional health. Southeast Asia·2026

相关实验视频

Updated: Jan 13, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K

利用现有知识用于药物重新使用:解决未满足医疗需求的理性方法.

Rohit Pandey1, Nandini Sharma2, Bhawna Sharma3

  • 1Department of Pharmaceutical Chemistry, Dr. K. N. Modi Institute of Pharmaceutical Education and Research, Modinagar, Ghaziabad, UP, India.

Reviews on recent clinical trials
|January 9, 2026
PubMed
概括

药物再利用为现有药物找到新的用途,节省时间和成本. 本综述探讨了可持续医疗保健的机制,方法和挑战.

关键词:
药物重新定位是药物重新定位.药物开发是药物开发的过程.发现药物的发现.药物重新定位 药物重新定位伦理考虑 伦理考虑非目标效应的非目标效应患者为中心的护理.多种药理学 多种药理学监管方面的考虑.

更多相关视频

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.7K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

相关实验视频

Last Updated: Jan 13, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.7K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

科学领域:

  • 药理学和药物发现
  • 翻译医学是一种翻译医学.

背景情况:

  • 药物重定向通过利用现有的药物安全性和有效性数据,为开发新疗法提供了具有成本效益的战略.
  • 这种方法与新药发现相比,大大加快了药物开发时间表.

研究的目的:

  • 提供与药物重用相关的机制,战略和挑战的全面概述.
  • 讨论多药理学和计算/实验方法在识别重用机会中的作用.
  • 解决与药物重新用途相关的监管和伦理方面的考虑.

主要方法:

  • 审查现有的关于药物重用机制和策略的文献.
  • 分析计算和实验方法来识别新的药物指示.
  • 检查案例研究证明成功的药物重定向在各种治疗领域的检查.

主要成果:

  • 药物重定向在各种领域是有效的,包括瘤学和罕见疾病.
  • 关键的挑战包括对可靠的监管和临床数据的要求.
  • 多药理学和非目标效应是重新使用的关键考虑因素.

结论:

  • 药物重新定位对加速向患者提供新型治疗方法具有重大前景.
  • 它通过优化资源利用,为更可持续的医疗保健系统做出了贡献.
  • 了解生物系统和疾病机制的进步将进一步增强药物重定向对患者结果的影响.